TRXC - Why TransEnterix Stock Surged Today and Then Gave Up All its Gains
Shares of TransEnterix (NYSEMKT: TRXC) soared as much as 27.2% on Wednesday before surrendering their gains and finishing the trading day down less than 1%.
TransEnterix received approval in Europe on Tuesday for its Intelligent Surgical Unit (ISU), which adds machine-vision functions to the Senhance Surgical System. Senhance digital laparoscopic surgery programs in Europe will now have access to this innovative augmented-intelligence technology.
"We have already successfully implemented augmented intelligence in the U.S. with the Senhance System after receiving [Food and Drug Administration] clearance last year," CEO Anthony Fernando said in a press release. "We are pleased to expand this important capability to our broader global user base."
For further details see:
Why TransEnterix Stock Surged Today and Then Gave Up All its Gains